Skip to content
Open access

Family History among Breast Cancer Patients Attending the National Cancer Centre in Benghazi - Cross-Sectional Study.

Jul 2026 · Libyan journal of medical research · Vol 20, pp. 436-442 · 0 citations · 22 references

TL;DR

More than half of the patients (55%) reported a positive family history of breast cancer, suggesting that hereditary factors may play an important role in the occurrence of the disease among this population of women.

Abstract

Background: Breast cancer (BC) is a type of cancer that develops in the cells of the breast. It is the most common cancer diagnosed in women worldwide, although it can also occur in men. Family history is a major risk factor for breast cancer. Familial breast cancer, defined by the clustering of cases within a pedigree, accounts for roughly 20% to 30% of all diagnoses, while high-penetrance germline mutations in genes such as BRCA1 and BRCA2 contribute to 5% to 10% of the total burden. Aim: To determine the percentage of family history of breast cancer among patients attending the National Cancer Centre of Benghazi. Methodology: A cross-sectional study was conducted using convenience sampling of all patients with files during 2023. Results: A total of 124 female patients, of whom 34% were aged 46 to 55 and 28% aged 36 to 45. The mean age of patients was 51.8 ±11.6, the minimum age was 31, and the maximum age was 81. 55% had a family history of breast cancer. Conclusion: This study highlights the significant presence of family history among breast cancer patients attending the National Cancer Centre of Benghazi. More than half of the patients (55%) reported a positive family history of breast cancer, suggesting that hereditary factors may play an important role in the occurrence of the disease among this population. These results emphasise the importance of increasing awareness about family history as a major risk factor for breast cancer and highlight the need for improved screening, early detection programs, and genetic counselling for women with a positive family history to reduce the burden of the disease.

Read PDF

Similar papers

Jul 2026

A Decade of Hereditary Cancer Genetic Testing Results in Asian Indian population: Retrospective Study.

This retrospective study showcases the largest comprehensive characterization of the hereditary cancer genetics in India and South Asian region till date, demonstrating a substantial burden of inherited cancer susceptibility and distinct gene-cancer associations across major tumor types.

R. Menon, L. Mahadevan, A. Dineshkumar et al. · 0 citations
Open access Jul 2026

Genetic profiling of healthy family members of breast and ovarian cancer patients in Estonia

The findings highlight the value of genetic testing in identifying at-risk individuals among HFMs of BCOC patients and the expansion of HFM testing in Estonia reflects increased public awareness and clinical integration of genetic risk assessment in cancer prevention strategies.

M. Tooming, Kadri Rekker, K. Toome et al. · 0 citations
Open access Jul 2026

Impact of lifestyle, familial history and environmental factors on breast cancer development among 80 women in Calabar Nigeria

The results of the study indicated that lifestyle, environmental, and familial history factors did not have a significant impact on the development of breast cancer among the participants, as the associated probability values were greater than the level of significance for all the three factors.

Anita Yemi-Odae Nelson, Cecilia James Sunday, Lucy E. Afahanam et al. · 0 citations
Open access Jul 2026

Reproductive Risk Factors and Their Association with Breast Cancer in Women of Central India

Several reproductive factors are significantly associated with breast cancer risk among women in Central India and promotion of breastfeeding and identification of women with adverse reproductive profiles may facilitate early screening and risk reduction strategies.

Sriyansh Jain, R. Arjariya, Sunil Kumar Saxena et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.